{"title":"接种Covid-19疫苗后的不良事件:来自尼日利亚河流州州登记和监测系统的结果","authors":"C. Eze-Emiri","doi":"10.47363/jcet/2023(4)134","DOIUrl":null,"url":null,"abstract":"Introduction: The manufacture of COVID-19 vaccines was a response to the COVID-19 public health emergency. Four of the WHO approved COVID-19 vaccines were available and administered in Nigeria.","PeriodicalId":102800,"journal":{"name":"Journal of Clinical Epidemiology & Toxicology","volume":"273 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adverse Events Following Immunization with Covid-19 Vaccines: Results from the State Registry and Surveillance System in Rivers State, Nigeria\",\"authors\":\"C. Eze-Emiri\",\"doi\":\"10.47363/jcet/2023(4)134\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: The manufacture of COVID-19 vaccines was a response to the COVID-19 public health emergency. Four of the WHO approved COVID-19 vaccines were available and administered in Nigeria.\",\"PeriodicalId\":102800,\"journal\":{\"name\":\"Journal of Clinical Epidemiology & Toxicology\",\"volume\":\"273 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Epidemiology & Toxicology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47363/jcet/2023(4)134\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Epidemiology & Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47363/jcet/2023(4)134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Adverse Events Following Immunization with Covid-19 Vaccines: Results from the State Registry and Surveillance System in Rivers State, Nigeria
Introduction: The manufacture of COVID-19 vaccines was a response to the COVID-19 public health emergency. Four of the WHO approved COVID-19 vaccines were available and administered in Nigeria.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
